title: Studies of lipid profile, liver function and kidney function parameters of rat plasma after chronic administration of "Sulavajrini Vatika".
abstract: The successful use of Ayurvedic medicines is for many years but there is no guideline for studying the toxicity of these preparations through preclinical or clinical investigations. The present study was conducted to evaluate the effect of conventionally prepared Sulavajrini Vatika (SBB), an Ayurvedic formulation on various biochemical parameters of experimental animals after chronic administration. The animal used was albino rats (Rattus norvegicus: Sprague-Dawley strain) and SBB was administered orally at a single dose of 100 mg kg(-1) b.wt. day(-1), up to 62 days. During the study, forty rats, equally of both sexes, were randomly grouped into four where one male and one female group were used as control and other groups were used as test. Among the lipid components, Triglyceride (TG) was decreased very high significantly in both sexes of animal. The decrease of Total Cholesterol (TC), Very Low Density Lipoprotein (VLDL) and high-density lipoprotein (HDL) were also highly significant. Low Density Lipoprotein (LDL) decreased in all SBB treated group. In the liver function parameters, the total protein and albumin content were increased very high significantly in both sexes of rat. But the bilirubin was decreased insignificantly in male and female rats. Serum Glutamic Pyruvic Transaminase (GPT), Glutamic Oxaloacetic Transaminase (GOT) and Alkaline Phosphatase (ALP) were decreased in all treated animals and it was very high significant. In case of kidney function parameters, creatinine was increased very high significantly but the urea was decreased very high significantly in both sexes of rat. The decrease in uric acid was not significant in none of the sexes of rat. The present study confirms that SBB can be contributory for the complications in diabetics with hyperlipidemia and nephropathy as it lowers most of the lipids components and improves liver function and kidney function parameters.
authors.affiliation: Department of Pharmacy, Jahangirnagar University, Bangladesh.
authors.forename: N Krishna
authors.initials: NK
authors.lastname: Kundu
authors.forename: M Obayed
authors.initials: MO
authors.lastname: Ullah
authors.forename: Kaiser
authors.initials: K
authors.lastname: Hamid
authors.forename: Kaniz Fatima
authors.initials: KF
authors.lastname: Urmi
authors.forename: Israt Jahan
authors.initials: IJ
authors.lastname: Bulbul
authors.forename: Muhammad Atikul Islam
authors.initials: MA
authors.lastname: Khan
authors.forename: Momita
authors.initials: M
authors.lastname: Akter
authors.forename: M S K
authors.initials: MS
authors.lastname: Choudhuri
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D005260:Female; D007668:Kidney / Q000187:drug effects*; D008055:Lipids / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000187:drug effects*; D008111:Liver Function Tests; D008297:Male; D008515:Medicine, Ayurvedic; D028321:Plant Preparations / Q000008:administration & dosage / Q000627:therapeutic use*; D010949:Plasma / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000097:blood; D014508:Urea / Q000378:metabolism
chemical_list: D008055:Lipids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D028321:Plant Preparations; C584239:Sulavajrini Vatika; D014280:Triglycerides; D014508:Urea; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase